Trade Summary

3 days ago, Wentworth Kerry, serving as CHIEF REGULATORY OFFICER at Nuvation Bio Inc. (NUVB), sold 63,000 shares at $6.02 per share, for a total transaction value of $379,190.70. Following this transaction, Wentworth Kerry now holds 53,000 shares of NUVB.

This sale represents a 54.31% decrease in Wentworth Kerry's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 7:07 PM ET, 1 day after the trade was made.

Nuvation Bio Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.